Migraine patients should be cautiously followed for risk factors leading to cardiovascular disease

被引:2
|
作者
Ferreira da Silva, Ivan Rocha [1 ]
de Freitas, Gabriel R. [2 ]
机构
[1] Cleveland Clin Fdn, Cerebrovasc Ctr, Neurocrit Care Unit, Cleveland, OH 44195 USA
[2] Hosp Quinta DOr DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil
关键词
brain ischemia; cerebrovascular disorders; migraine; stroke; PATENT FORAMEN OVALE; ISCHEMIC-STROKE; CEREBRAL INFARCTION; SEPTAL REPAIR; YOUNG-ADULTS; HEADACHE; WOMEN; CLOSURE; BRAIN; AURA;
D O I
10.1590/S0004-282X2013000200012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Migraine and ischemic strokes are two of the most prevalent diseases worldwide. Besides having a coincident symptomatology, for long researchers have been searching for a possible causal relation between these diseases. Current evidence based on data suggest that patients with aura migraine could have a doubled risk of developing an ischemic stroke, when compared to the rest of the population. At the same time, migraine sufferers apparently have higher incidences of risk factors for cardiovascular events. The aim of this review was not only to dissect some of the more compelling evidence based on data regarding this association, but also to discuss the possible clinical and therapeutic implications.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [31] RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Alpert, M. A.
    CARDIOLOGY, 2013, 125 : 339 - 339
  • [32] RISK FACTORS FOR CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Alpert, M. A.
    CARDIOLOGY, 2014, 128 : 90 - 90
  • [33] How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?
    Ruggenenti, Piero
    Remuzzi, Giuseppe
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (03): : 126 - 127
  • [34] How should patients with, or at risk of, cardiovascular disease be screened for chronic kidney disease?
    Piero Ruggenenti
    Giuseppe Remuzzi
    Nature Clinical Practice Nephrology, 2007, 3 : 126 - 127
  • [35] Safety of Erenumab among Patients with Migraine using Triptans or With Cardiovascular Risk Factors
    Winner, P.
    Reuter, U.
    Dodick, D.
    Kudrow, D.
    Rozniecki, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Picard, H.
    Mikol, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 408 - 408
  • [36] Enoxaparin should be used cautiously in patients with end-stage renal disease
    Kalus, JS
    Spencer, AP
    PHARMACOTHERAPY, 2001, 21 (08): : 1015 - 1016
  • [37] Contribution of Migraine to Cardiovascular Disease Risk Prediction
    Rist, Pamela M.
    Buring, Julie E.
    Cook, Nancy R.
    Kurth, Tobias
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (23) : 2246 - 2254
  • [38] Migraine with and without Aura and Risk for Cardiovascular Disease
    Vargas, Bert B.
    Dodick, David W.
    Wingerchuk, Dean M.
    Demaerschalk, Bart M.
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (05) : 427 - 433
  • [39] MIGRAINE FREQUENCY AND RISK OF CARDIOVASCULAR DISEASE IN WOMEN
    Gordon, James M.
    NEUROLOGY, 2010, 74 (07) : 615 - 616
  • [40] Migraine frequency and risk of cardiovascular disease in women
    Kurth, Tobias
    Schuerks, Markus
    Logroscino, Giancarlo
    Buring, Julie E.
    NEUROLOGY, 2009, 73 (08) : 581 - 588